Skip to main content

Zoth Lota S.'s Form 4 filing

Inovio Pharmaceuticals, Inc. (INO) · filed May 17, 2022

Accession no.
0001055726-22-000039
Filed
May 17, 2022
Trade date
May 13-16, 2022
Filing delay
4 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 2 non-derivative transactions and 3 derivative transactions. Open-market sales total $7.13K. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Zoth Lota S.CIK 0001278219Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
May 13, 2022Common StockMOption exerciseAcquired+18,000–F1–43,016Direct
May 16, 2022Common StockSSaleDisposed−3,600$1.98−$7,12839,416Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
May 13, 2022Common StockMOption exerciseDisposed−18,000$0.00$00Direct
May 16, 2022Common StockAGrant or awardAcquired+19,000$0.00$019,000Direct
May 16, 2022Common StockAGrant or awardAcquired+28,000$0.00$028,000Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 13, 2022.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)